Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia.

Vasc Cell · 2013 · PMC3703285 · PMID 23816205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Post-ischemic limb perfusion following AAV-VEGF-A administration was also somewhat improved at day 7 and 14 when compared to control AAV-LacZ-treated mice, however, the differences did not reach statistical significance (Figure 5 A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.